Is Genotropin Approved for Height Increase in Healthy Children?
No, Genotropin (somatropin, recombinant human growth hormone) is not approved for use in healthy children to increase height. The FDA approves it only for specific medical conditions causing growth failure, such as growth hormone deficiency (GHD), Turner syndrome, Prader-Willi syndrome, chronic kidney disease, or idiopathic short stature (ISS) where height is below the 1.2 percentile for age and growth velocity is low.[1][2]
What Conditions Qualify for Genotropin Treatment?
Genotropin treats short stature linked to diagnosed deficiencies:
- Growth hormone deficiency: Confirmed by stimulation tests showing low GH levels.
- Idiopathic short stature (ISS): Height <1.2nd percentile with normal GH levels, but only if predicted adult height is compromised and growth rate is inadequate.
- Other FDA-approved uses: Noonan syndrome, SHOX gene deficiency, small for gestational age (SGA) without catch-up growth by age 2-4.
Healthy children with normal GH levels and height within normal percentiles do not qualify.[1][3]
Does It Work for Height in Healthy Kids Anyway?
Limited evidence suggests modest height gains (1-2 inches) in non-GHD children with short stature, but studies show no benefit—and potential risks—for truly healthy kids at normal heights. A 2002 New England Journal of Medicine trial on ISS kids gained ~1.6 inches more than placebo, but long-term adult height benefits are inconsistent, and use in non-deficient kids lacks robust data.[4][5]
Off-label use occurs rarely, but experts (e.g., Pediatric Endocrine Society) advise against it due to insufficient evidence of meaningful adult height increase.[6]
What Are the Risks and Side Effects?
Growth hormone can cause:
- Slipped capital femoral epiphysis (hip joint issue).
- Scoliosis progression.
- Glucose intolerance or type 2 diabetes risk.
- Increased intracranial pressure.
- Fluid retention, carpal tunnel, or joint pain.
- Potential cancer risk (e.g., leukemia in predisposed kids), though not proven causal.
- Cost: $20,000-$50,000/year, often not covered by insurance for off-label use.[2][7]
Long-term safety in healthy kids is unknown; monitoring requires frequent blood tests and bone age X-rays.[3]
Legal and Ethical Considerations
Prescribing Genotropin for cosmetic height increase in healthy children is off-label and discouraged by guidelines from the FDA, AAP, and Endocrine Society. It's illegal to market for unapproved uses, and pediatricians risk liability. Parents seeking this often turn to "growth clinics," but outcomes are poor relative to risks.[6][8]
Alternatives for Concerned Parents